文献速递心境障碍

重度抑郁症患者治疗感知有用性的世界精神健康调查结果

Findings From World Mental Health Surveys of the Perceived Helpfulness of Treatment for Patients With Major Depressive Disorder.
PubMed 文献 · JAMA Psychiatry · 2020-01-01

该研究基于16国17项社区流行病学调查,分析终生DSM-IV重度抑郁症(MDD)患者感知治疗有用性的两个成分:治疗师被感知有用及患者坚持求助。结果显示,看到第10位治疗师时累积有用概率达93.9%,但仅21.5%患者坚持到那时,68.2%患者曾获得感知有用的治疗。

要点

  • 感知治疗有用性由治疗师被感知有用和患者坚持求助共同决定。
  • 首次治疗年龄较大、教育水平较高与单次治疗被感知有用相关。
  • 治疗延迟较短和接受精神科专家药物治疗与坚持求助相关。

核心结论

  • MDD患者若在多达9次无帮助治疗后仍坚持求助,获得感知有用治疗的概率可能显著增加。

研究设计与样本

  • 协调系列社区流行病学调查,使用世界卫生组织世界精神健康调查,17项调查覆盖16国(8项高收入国家,9项中低收入国家),数据收集从2002-2003年(黎巴嫩)至2016-2017年(保加利亚)。
  • 纳入终生有治疗史的重度抑郁症(MDD)患者,分析社会经济特征、终生共病、治疗类型、治疗时机和国家收入水平。

主要发现

  • 汇总应答率68.3%(n=117 616),首次抑郁治疗平均年龄34.8岁(SE 0.3),女性占69.4%。
  • 2726名终生治疗MDD患者中,看到最多10位治疗师后累积有用概率为93.9%(SE 1.2%),但仅21.5%(SE 3.2%)患者坚持超过9次无帮助治疗,68.2%(SE 1.1%)患者曾获得感知有用的治疗。
  • 感知治疗有用的概率与以下因素正相关:首次治疗年龄较大(AOR 1.02;95% CI 1.01-1.03)、教育水平较高(低 vs 高:AOR 0.48;95% CI 0.33-0.70;低平均 vs 高:AOR 0.62;95% CI 0.44-0.89;高平均 vs 高:AOR 0.67;95% CI 0.49-0.91)、首次发作后治疗延迟较短(AOR 0.98;95% CI 0.97-0.99)、从精神健康专家处获得药物治疗(AOR 2.91;95% CI 2.04-4.15)。
  • 分解分析显示,首次治疗年龄(AOR 1.02;95% CI 1.01-1.02)和教育水平(低 vs 高:AOR 0.48;95% CI 0.33-0.70;低平均 vs 高:AOR 0.62;95% CI 0.44-0.89;高平均 vs 高:AOR 0.67;95% CI 0.49-0.91)仅与单次治疗被感知有用相关,而治疗延迟(AOR 0.98;95% CI 0.97-0.99)和治疗类型(AOR 3.43;95% CI 2.51-4.70)仅与坚持求助相关。

关键数值与推荐

  • 看到最多10位治疗师后累积有用概率93.9%(SE 1.2%)。
  • 坚持超过9次无帮助治疗的患者比例21.5%(SE 3.2%)。
  • 曾获得感知有用治疗的患者比例68.2%(SE 1.1%)。

临床怎么用

  • 临床应鼓励MDD患者在无帮助治疗后坚持求助,以增加获得感知有用治疗的机会。
  • 关注首次治疗年龄较大、教育水平较低、治疗延迟较长及未接受精神科专家药物治疗的患者,这些因素与感知有用性较低相关。

局限性

  • 研究为观察性设计,无法确定因果关系。
  • 感知有用性基于患者主观报告,可能存在回忆偏倚。
  • 调查覆盖国家有限,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: The perceived helpfulness of treatment is an important patient-centered measure that is a joint function of whether treatment professionals are perceived as helpful and whether patients persist in help-seeking after previous unhelpful treatments. OBJECTIVE: To examine the prevalence and factors associated with the 2 main components of perceived helpfulness of treatment in a representative sample of individuals with a lifetime history of DSM-IV major depressive disorder (MDD). DESIGN, SETTING, AND PARTICIPANTS: This study examined the results of a coordinated series of community epidemiologic surveys of noninstitutionalized adults using the World Health Organization World Mental Health surveys. Seventeen surveys were conducted in 16 countries (8 surveys in high-income countries and 9 in low- and middle-income countries). The dates of data collection ranged from 2002 to 2003 (Lebanon) to 2016 to 2017 (Bulgaria). Participants included those with a lifetime history of treated MDD. Data analyses were conducted from April 2019 to January 2020. Data on socioeconomic characteristics, lifetime comorbid conditions (eg, anxiety and substance use disorders), treatment type, treatment timing, and country income level were collected. MAIN OUTCOMES AND MEASURES: Conditional probabilities of helpful treatment after seeing between 1 and 5 professionals; persistence in help-seeking after between 1 and 4 unhelpful treatments; and ever obtaining helpful treatment regardless of number of professionals seen. RESULTS: Survey response rates ranged from 50.4% (Poland) to 97.2% (Medellín, Columbia), with a pooled response rate of 68.3% (n = 117 616) across surveys. Mean (SE) age at first depression treatment was 34.8 (0.3) years, and 69.4% were female. Of 2726 people with a lifetime history of treatment of MDD, the cumulative probability (SE) of all respondents pooled across countries of helpful treatment after seeing up to 10 professionals was 93.9% (1.2%), but only 21.5% (3.2%) of patients persisted that long (ie, beyond 9 unhelpful treatments), resulting in 68.2% (1.1%) of patients ever receiving treatment that they perceived as helpful. The probability of perceiving treatment as helpful increased in association with 4 factors: older age at initiating treatment (adjusted odds ratio [AOR], 1.02; 95% CI, 1.01-1.03), higher educational level (low: AOR, 0.48; 95% CI, 0.33-0.70; low-average: AOR, 0.62; 95% CI, 0.44-0.89; high average: AOR, 0.67; 95% CI, 0.49-0.91 vs high educational level), shorter delay in initiating treatment after first onset (AOR, 0.98; 95% CI, 0.97-0.99), and medication received from a mental health specialist (AOR, 2.91; 95% CI, 2.04-4.15). Decomposition analysis showed that the first 2 of these 4 factors were associated with only the conditional probability of an individual treatment professional being perceived as helpful (age at first depression treatment: AOR, 1.02; 95% CI, 1.01-1.02; educational level: low: AOR, 0.48; 95% CI, 0.33-0.70; low-average: AOR, 0.62; 95% CI, 0.44-0.89; high-average: AOR, 0.67; 95% CI, 0.49-0.91 vs high educational level), whereas the latter 2 factors were associated with only persistence (treatment delay: AOR, 0.98; 95% CI, 0.97-0.99; treatment type: AOR, 3.43; 95% CI, 2.51-4.70). CONCLUSIONS AND RELEVANCE: The probability that patients with MDD obtain treatment that they consider helpful might increase, perhaps markedly, if they persisted in help-seeking after unhelpful treatments with up to 9 prior professionals.

来源:JAMA Psychiatry,查看原文。版权归原作者所有。

引用

  1. Harris MG, Kazdin AE, Chiu WT, et al. Findings From World Mental Health Surveys of the Perceived Helpfulness of Treatment for Patients With Major Depressive Disorder. JAMA Psychiatry. 2020. PMID: 32432716. doi:10.1001/jamapsychiatry.2020.1107

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。